+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome



Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome



American Journal of Kidney Diseases 20(2): 150-158



Current studies indicate that a thrombotic microangiopathy (TMA) identifies patients with systemic lupus erythematosus (SLE) who are at high risk of progressing to end-stage renal disease. We have observed two patients with SLE and one patient with a primary antiphospholipid syndrome (APS) who developed acute renal insufficiency with thrombocytopenia. Renal biopsies showed a TMA characterized by thrombi or by cellular and mucoid intimal hyperplasia of small arteries and arterioles. No arterial or arteriolar immune-complex deposits were detected by immunofluorescent or electron microscopy. Biopsies from one SLE patient and the APS patient showed no immune-complex glomerular disease. Both had serum antiphospholipid antibodies (aPL). aPL were not detected in the serum of the other SLE patient who had an active lupus nephritis. Acute renal failure and thrombocytopenia resolved in each case following treatment by plasmapheresis or prednisone and heparin. None of the patients were initially treated with cytotoxic drugs. As more knowledge is gained, the accurate identification of renal vascular lesions in SLE or related diseases could influence renal prognosis and choice of therapy. The cases reported here provide further evidence that a TMA can cause acute renal failure independent of lupus nephritis. TMA should be distinguished from other forms of renal vascular disease, particularly a noninflammatory lupus microangiopathy, which is probably mediated by subendothelial immune-complex deposits. The absence of immunoglobulin deposits in vessels involved by a TMA indicates that microvascular thrombosis is promoted by mechanisms other than those usually attributed to immune-complex disease. Phospholipid reactive antibodies may be pathogenetic in some cases.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 033185692

Download citation: RISBibTeXText

PMID: 1496968

DOI: 10.1016/s0272-6386(12)80543-9


Related references

Thrombotic microangiopathy involving the gallbladder as an unusual manifestation of systemic lupus erythematosus and antiphospholipid syndrome: Case report and review of the literature. World Journal of Gastroenterology 12(44): 7206-7209, 2006

Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature. Seminars in Arthritis and Rheumatism 49(1): 74-83, 2019

Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome. Clinical and Experimental Rheumatology 33(4): 503-508, 2015

"Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome. American Journal of Kidney Diseases 35(6): 1193-1206, 2000

SLE and antiphospholipid syndrome: 168. Dyslipidaemia, Hyperhomocysteinaemia and Antiphospholipid Antibodies as Risk Factors of Thrombotic Complications in Patients with Systemic Lupus Erythematosus. Rheumatology 50(Suppl. 3): Iii106-Iii110, 2011

Relationship between hypertension and thrombotic events in patients with antiphospholipid syndrome associated with systemic lupus erythematosus. Arthritis & Rheumatism 42(9 Suppl. ): S363, 1999

Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology 40(8): 863-867, 2001

Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome. Wiener Klinische Wochenschrift 112(15-16): 707-710, 2000

Renal thrombotic microangiopathy and antiphospholipid syndrome nephropathy in a patient with lupus nephritis. Nihon Jinzo Gakkai Shi 58(1): 45-54, 2016

Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopenia. European Journal of Internal Medicine 15(3): 162-167, 2004

Renal thrombotic microangiopathy and systemic lupus erythematosus Clinical correlations and long-term renal survival. Journal of the American Society of Nephrology 5(3): 347, 1994

Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival. Nephrology, Dialysis, Transplantation 13(2): 298-304, 1998

Acute renal failure secondary to thrombotic microangiopathy in a patient with systemic lupus erythematosus. Medicina Clinica 89(20): 870-872, 1987

Eltrombopag in systemic lupus erythematosus with antiphospholipid syndrome: thrombotic events. Lupus 25(3): 331, 2016

Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome. European Journal of Radiology 81(6): 1335-1339, 2012